Cooperative Centers for Experimental Hematology (CCEHs) (U54- Clinical Trial Not Allowed)
- Response deadline
- Sep 30, 2026 Due in 29 days
- Date posted
- Aug 31, 2026
- Source
- Open notice
Description
The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications for Centers within the NIDDK Cooperative Centers of Experimental in Hematology (CCEH) Program. Each Center will support one to three Biomedical Research Cores and an Administrative Core, including an Enrichment Program. Each Center is expected to work collaboratively with NIDDK, the Hematology Coordinating Center (HCC), and the other CCEH Centers. The CCEH Program is designed to increase access to critical research resources and expertise unique to nonmalignant hematology research. By providing innovative technology, resources, and expertise to the greater hematology research community, the program will serve as a national hub, aimed at recruiting and retaining both junior scientists just beginning their careers in the field as well as established investigators from other domains.
Classifications
- NAICS93.847
Documents (1)
- RFA-DK-27-127-Full-Announcement.htmltext/html;charset=UTF-8192 KBNot yet available
Contacts
- niddk_kuh@nih.gov301-402-2541
Similar contracts
- Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)Due Nov 6, 2026
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)Due Nov 9, 2026
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)Due Nov 9, 2026
- Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)Due Oct 20, 2026
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)Due Feb 10, 2027
- Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)Due Oct 9, 2026